Search

Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location, and its third on Long Island, will open for patient care on April 8 with more than 180 dedicated medical and professional staff, all of whom are MSK employees.

… Thursday, April 4, 2019 Memorial Sloan Kettering Cancer Center (MSK) announced its recommitment to communities across Long Island today with the dedication of MSK Nassau, a light-filled 114,000-square-foot outpatient cancer treatment facility centrally located along Hempstead Turnpike. MSK’s newest location

We love our smartphones, but could they be harming our health? An MSK expert weighs in.

… Monday, May 20, 2019 Summary A government-funded study published last year raised concerns about the dangers of cell phone radiation. An MSK radiation expert discusses the study’s limitations and weighs in on the evidence related to cell phone use and cancer risk. Back in 1993, a Florida resident named

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.

… Wednesday, January 28, 2026 VIDEO | 03:35 Watch How Two MSK Labs Came Together to Give a Stage 4 Lung Cancer Patient More Time Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients

Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.

… Friday, December 27, 2019 Summary Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials. It was Monday, July 2, 2018, and the early morning air in Manhattan was humid, thick with anticipation for the upcoming Independence Day holiday. Memorial Sloan Kettering

Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study.

… Tuesday, October 8, 2019 Despite the intention to reduce testosterone temporarily, androgen deprivation therapy (ADT) may lower it for prolonged periods in patients over the age of 65 or those who take ADT for more than six months, according to the results of our recent retrospective study. Given the

First-year students reflect on the impact of the first-year core curriculum on their careers.

… Thursday, April 1, 2010 Our current first-year students arrived on July 27, 2009, and during their first laboratory rotation began laying the foundation for developing a dissertation. After five weeks of bench work, they entered the classroom to tackle the core course, taking breaks from this didactic

Charles Swanton of Cancer Research UK and University College London was one of the recipients of the 2021 Paul Marks Prize for Cancer Research.

… Thursday, March 17, 2022 The Paul Marks Prize for Cancer Research was created by the Boards of Memorial Sloan Kettering Cancer Center to honor the late Paul Marks , who served as President and CEO of MSK for almost 20 years, beginning in 1980. Awarded every other year since 2001, the prize recognizes

Computational biology is helping to bring predictive power and precision to oncology.

… Wednesday, April 1, 2020 By Julie Grisham It was July 17, 2017, when Albert Kuchler found an unusual lump in his neck. As a retired oral surgeon, he knew this was cause for concern. He called his friend and colleague Jatin Shah , a member of Memorial Sloan Kettering’s Head and Neck Service, to see if

Research led by investigators at Memorial Sloan Kettering has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory.

… Thursday, September 4, 2014 Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer

MSK research team identifies unique markers of inflammation and neurodegeneration found in cerebrospinal fluid of cancer patients with altered mental status after initial SARS-CoV-2 infection, as likely cause of neurologic dysfunction.

… Tuesday, March 2, 2021 Unique markers of inflammation and neurodegeneration in cerebrospinal fluid were present several weeks after initial SARS-CoV-2 infection in cancer patients with neurologic symptoms. These inflammatory cytokines were absent in plasma and likely drove the neurologic dysfunction,